The US Federal Reserve has cut interest rates by 50 basis points to address rising unemployment and bolster demand. Historically, such cuts have led to market corrections, but current US GDP growth suggests a different outcome. Indian markets, with strong GDP growth and robust liquidity, may remain resilient despite global trends.
Varun Beverages shares drop 1.72% as Sensex falls (27-09-2024)
The stock quoted a 52-week high of Rs 682.84 and a 52-week low of Rs 331.28.
NSE SME Bikewo Green Tech stumbles in market debut (27-09-2024)
Shares of Bikewo Green Tech were trading at Rs 47.25 on the NSE, a discount of 23.79% compared with the issue price of Rs 62.
MUDA Scam: Congress chief Mallikarjun Kharge shows solidarity with CM Siddaramaiah, rejects chances of resignation (27-09-2024)
Congress President Mallikarjun Kharge announced the party’s support for Karnataka CM Siddaramaiah amid allegations of the MUDA scam. Kharge rejected calls for Siddaramaiah’s resignation, comparing the situation to Narendra Modi’s tenure during the 2002 Godhra riots. He emphasized that targeting Siddaramaiah aims to damage the Congress party’s image.
Max Healthcare shares drop 0.49% as Sensex falls (27-09-2024)
A total of 13,763 shares changed hands on the counter till 01:44PM (IST)
Sequent Scientific – Indian story in Global Animal Pharma Space (27-09-2024)
Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore merger
Sequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and integrated capabilities across the global pharmaceutical market. The merger will expand Sequent’s capital base and is expected to enhance marketing presence, facilitate backward integration, and create procurement synergies.
The combined entities will have 16 manufacturing plants out of which 10 are US Food and Drug Administration approved plants.
2 top stock recommendations from Soni Patnaik (27-09-2024)
However, any closer dip towards 26,000, 25,800 can act as a strong support as well. On the higher side, 26,300 intraday is acting as a resistance. There is some amount of call writing that can be seen around those levels.
Alembic Pharma gets USFDA nod for Paliperidone extended-release Tablets (27-09-2024)
Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paliperidone extended-release tablets.
Indian Hotels shares gain 0.6% as Sensex falls (27-09-2024)
On the technical charts, the RSI of the stock stood at 66.32.